Clinical Trial Update: Neoadjuvant Long-course Chemoradiotherapy Followed by Immunotherapy for Locally Advanced Mid-low Rectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of neoadjuvant long-course chemoradiotherapy followed by immunotherapy for locally advanced mid-low rectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Peking University People's Hospital | Conditions: Locally Advanced Rectal Cancer | Phase 2 | Status: COMPLETED